⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1883921 | 0.77 | — | — | |
| SCHEMBL55913 | 0.76 | — | — | |
| SCHEMBL8330698 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL18059973 | 0.74 | — | — | |
| SCHEMBL10580773 | 0.74 | — | — | |
| SCHEMBL7352618 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL1845285 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL285086 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL4696499 | 0.72 | GMNN (0.32) | — | |
| SCHEMBL3361601 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4263518-A1 | NEW QUINAZOLINONE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2023-10-25 | — | — | EP | claimed |
| US-20230331682-A1 | NEW QUINAZOLINONE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2023-10-19 | — | — | US | claimed |
| CN-116768806-A | Substituted 1,2, 3-triazole compound, preparation method thereof and application thereof in preventing and treating plant diseases | 中国农业大学 | 2023-09-19 | — | — | CN | claimed |
| CN-116601147-A | Novel quinazolinone derivatives | 豪夫迈·罗氏有限公司 | 2023-08-15 | — | — | CN | claimed |
| WO-2022129259-A1 | NEW QUINAZOLINONE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2022-06-23 | — | — | WO | claimed |
| US-11261237-B2 | Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection | NORTHWESTERN UNIVERSITY (US) | 2022-03-01 | — | — | US | claimed |
| US-11207423-B2 | Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs | NORTHWESTERN UNIVERSITY (US) | 2021-12-28 | — | — | US | claimed |
| US-20200338212-A1 | NANOCARRIERS HAVING SURFACE CONJUGATED PEPTIDES AND USES THEREOF FOR SUSTAINED LOCAL RELEASE OF DRUGS | NORTHWESTERN UNIVERSITY | 2020-10-29 | — | — | US | claimed |
| US-10583199-B2 | Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs | NORTHWESTERN UNIVERSITY (US) | 2020-03-10 | — | — | US | claimed |
| US-20180371060-A1 | MODIFIED PIGMENT EPITHELIUM-DERIVED FACTOR (PEDF) PEPTIDES AND USES THEREOF FOR TREATING NEOVASCULAR DISEASES, INFLAMMATORY DISEASES, CANCER, AND FOR CYTOPROTECTION | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2018-12-27 | — | — | US | claimed |
| US-10081668-B2 | Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection | NORTHWESTERN UNIVERSITY (US) | 2018-09-25 | — | — | US | claimed |
| WO-2018089465-A1 | NANOCARRIERS HAVING SURFACE CONJUGATED PEPTIDES AND USES THEREOF FOR SUSTAINED LOCAL RELEASE OF DRUGS | NORTHWESTERN UNIVERSITY (US) | 2018-05-17 | — | — | WO | claimed |
| US-20180092988-A1 | NANOCARRIERS HAVING SURFACE CONJUGATED PEPTIDES AND USES THEREOF FOR SUSTAINED LOCAL RELEASE OF DRUGS | NORTHWESTERN UNIVERSITY (US) | 2018-04-05 | — | — | US | claimed |
| WO-2017189715-A1 | MODIFIED PIGMENT EPITHELIUM-DERIVED FACTOR (PEDF) PEPTIDES AND USES THEREOF FOR TREATING NEOVASCULAR DISEASES, INFLAMMATORY DISEASES, CANCER, AND FOR CYTOPROTECTION | NORTHWESTERN UNIVERSITY (US) | 2017-11-02 | — | — | WO | claimed |
| US-20170305998-A1 | MODIFIED PIGMENT EPITHELIUM-DERIVED FACTOR (PEDF) PEPTIDES AND USES THEREOF FOR TREATING NEOVASCULAR DISEASES, INFLAMMATORY DISEASES, CANCER, AND FOR CYTOPROTECTION | NORTHWESTERN UNIVERSITY (US) | 2017-10-26 | — | — | US | claimed |
| WO-1995032736-A1 | IMMOBILIZATION OF BIOLOGICALLY ACTIVE MATERIALS AND DIAGNOSTIC AGENTS IN CROSS-LINKED POLY(ORGANOPHOSPHAZENES) | THE PENN STATE RESEARCH FOUNDATION (US) | 1995-12-07 | — | — | WO | claimed |
| EP-4263518-A1 | NEW QUINAZOLINONE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2023-10-25 | — | — | EP | disclosed |
| US-20230331682-A1 | NEW QUINAZOLINONE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2023-10-19 | — | — | US | disclosed |
| US-5898062-A | DIMENSIONALLY STABLE AND PH SENSITIVE POLYPHOSPHAZENES HAVING CARBOXYLIC ACID OR ESTER SIDE GROUPS; ANIONIC POLYMERS USED FOR CONTROLLED DRUG DELIVERY, BIOCOMPATIBLE COATINGS AND ION EXCHANGING MEMBRANES | THE PENN STATE RESEARCH FOUNDATION (US) | 1999-04-27 | — | — | US | disclosed |
| WO-1995032736-A1 | IMMOBILIZATION OF BIOLOGICALLY ACTIVE MATERIALS AND DIAGNOSTIC AGENTS IN CROSS-LINKED POLY(ORGANOPHOSPHAZENES) | THE PENN STATE RESEARCH FOUNDATION (US) | 1995-12-07 | — | — | WO | disclosed |